$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
ZD6474多少钱一盒?
2025-10-19 11:44:20
Check Details
Sorafenat怎么买?
2025-10-19 11:44:20
Check Details
Lenvaxen治疗甲状腺癌疗效怎么样?
2025-10-19 11:44:20
Check Details
Lenvaxen的价格多少呢?
2025-10-19 11:44:20
Check Details
仑伐替尼作用以及功效
2025-10-19 11:44:20
Check Details
仑伐替尼应如何购买呢?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗甲状腺癌的疗效怎样?
2025-10-19 11:44:20
Check Details
首款RET靶向药selpercatinib成功获批,非小细胞肺癌,甲状腺癌,甲状腺髓样癌都受益!
2025-10-19 11:44:20
Check Details
首次间变性甲状腺癌对PD-1阻断反应的临床试验!
2025-10-19 11:44:20
Check Details
Alkeran治疗甲状腺癌患者效果怎么样?
2025-10-19 11:44:20
Check Details
Melphalan治疗甲状腺癌的疗效怎么样?
2025-10-19 11:44:20
Check Details
左旋苯丙氨酸氮芥治疗甲状腺癌的疗效如何呢?
2025-10-19 11:44:20
Check Details
1
2
...
2490
2491
2492
2493
2494
2495
2496
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
2
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
3
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
4
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
5
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
6
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
7
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
8
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
9
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
10
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
11
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
12
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained